Company Filing History:
Years Active: 2001-2002
Title: Innovations of Peter Jonathan Gasking Butler in the Fight Against HIV
Introduction
Peter Jonathan Gasking Butler, an accomplished inventor based in Cambridge, GB, has made significant contributions in the field of biotechnology. With two innovative patents to his name, Butler's work aims to enhance the understanding and treatment of HIV infection.
Latest Patents
His latest patents include groundbreaking methods and compositions for combating HIV infection. One notable invention relates to an isolated nucleic acid that comprises two operatively linked binding sites for the HIV Rev protein. These sites incorporate a nucleation motif and an oligomerization motif, allowing the nucleic acid to bind Rev protein monomers with a higher degree of cooperativity compared to the wild-type RRE. Another patent focuses on assays for screening inhibitors of HIV, utilizing the same innovative nucleic acid that increases binding cooperativity.
Career Highlights
Butler’s career is marked by his role at Ribotargets Limited, where he has been instrumental in driving forward the development of therapeutic solutions aimed at combating viral infections. His inventions have the potential to revolutionize treatment protocols and provide new avenues for research in antiviral strategies.
Collaborations
Working alongside notable colleagues such as Jonathan Karn and Rodney Warren Zemmel, Butler has fostered a collaborative environment that encourages innovative approaches to complex biological challenges. These partnerships not only enhance the research quality but also extend the impact of their discoveries in the scientific community.
Conclusion
Peter Jonathan Gasking Butler stands out as a key figure in innovation related to HIV research. With his substantial patents and collaborations, he continues to pave the way for future advancements in the field of virology, making a lasting impact on treatments available for HIV infection.